CHEN Zhe 1,2,3,4,5 , WANG Qiqiong 1,2,3,4 , ZENG Linan 1,2,3,4 , HUANG Liang 1,2,3,4 , ZOU Kun 1,2,3,4 , LI Hailong 1,2,3,4 , JIA Zhijun 1,2,3,4,5 , CHENG Guo 4,6,7 , ZHANG Lingli 1,2,3,4
  • 1. Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 2. Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 3. NMPA Key Laboratory for Technical Research on Drug Products in vitro and in vivo Correlation, Chengdu 610041, P. R. China;
  • 4. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu 610041, P. R. China;
  • 5. West China School of Pharmacy, Sichuan University, Chengdu 610041, P. R. China;
  • 6. Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 7. Molecular Translational Medicine Laboratory, Translational Medicine Center of Sichuan University, Chengdu 610041, P. R. China;
ZHANG Lingli, Email: zhanglingli@scu.edu.cn
Export PDF Favorites Scan Get Citation

Rational drug use is a global concern. As one of the highest risk groups for drug use, children's rational drug use has always been concerned. Based on the previous research results of the research group, we developed evaluation indicator systems for assessing rational drug use to treat community-acquired pneumonia and primary nephrotic syndrome in children and proton pump inhibitors in pediatric intensive care units and finished empirical research. This study further summarizes and expounds the construction ideas of rational drug use evaluation indicators for children based on diseases or drugs, and provides a reference for constructing children's rational drug use evaluation indicators.

Citation: CHEN Zhe, WANG Qiqiong, ZENG Linan, HUANG Liang, ZOU Kun, LI Hailong, JIA Zhijun, CHENG Guo, ZHANG Lingli. Methods of developing evaluation indicators of rational drug use in children based on diseases or medicines. Chinese Journal of Evidence-Based Medicine, 2023, 23(6): 691-694. doi: 10.7507/1672-2531.202209126 Copy

  • Previous Article

    A governance framework for public health emergencies taking major infectious disease outbreaks as an example: a scoping review
  • Next Article

    Method of using RE-AIM framework to develop implementation outcome indicators